Free shipping on all orders over $ 500

Evogliptin

Cat. No. M27969
Evogliptin Structure
Synonym:

DA-1229

Size Price Availability Quantity
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Evogliptin (DA-1229) is an orally active DPP4 inhibitor with significant and sustained hypoglycaemic effects in mouse models. Evogliptin also inhibits the production of inflammatory and fibrotic signals in hepatocytes by inducing autophagy. Evogliptin can be used in studies of type 2 diabetes, osteoporosis, renal impairment and chronic liver inflammation.

Chemical Information
Molecular Weight 401.42
Formula C19H26F3N3O3
CAS Number 1222102-29-5
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Hye-Young Seo, et al. Int J Mol Sci. Evogliptin Directly Inhibits Inflammatory and Fibrotic Signaling in Isolated Liver Cells

[2] Ping Zou, et al. Expert Rev Clin Pharmacol. Evogliptin for the treatment option for type 2 diabetes: an update of the literature

[3] Taegon Hong, et al. Br J Clin Pharmacol. Pharmacokinetics and safety of evogliptin in hepatically impaired patients

[4] Y-D Ba, et al. Eur Rev Med Pharmacol Sci. Evogliptin attenuates bleomycin-induced lung fibrosis via inhibiting TGF-β/Smad signaling in fibroblast

[5] Xueying Tan, et al. Expert Opin Pharmacother. Evogliptin: a new dipeptidyl peptidase inhibitor for the treatment of type 2 diabetes

Related Dipeptidyl Peptidase Products
HAEGT

HAEGT is the first N-terminal 1-5 residues of glucagon like peptide-1 (GLP-1) peptide, and the sequence is His-Ala-Glu-Gly-Thr.

Diprotin B

Diprotin B is a dipeptidyl aminopeptidase IV (DPP IV) inhibitor.

Azaleatin

Azaleatin is an O-methylated flavonol isolated from Rhododendron species. Azaleatin is a dipeptidyl peptidase-IV inhibitor. Azaleatin can be used for the research of type-2 diabetes and obesity.

Sitagliptin fenilalanil hydrochloride

Sitagliptin fenilalanil hydrochloride is a dipeptidyl aminopeptidase 4 (DPP-4) inhibitor.

Lys-Ala-pNA

Lys-Ala-pNA is hydrolytic substrate the of dipeptidyl peptidase (DPP) II with Km of 0.42 mM.

  Catalog
Abmole Inhibitor Catalog




Keywords: Evogliptin, DA-1229 supplier, Dipeptidyl Peptidase, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.